Search Results

There are 7714 results for: content related to: A published pharmacogenetic algorithm was poorly predictive of tacrolimus clearance in an independent cohort of renal transplant recipients

  1. You have free access to this content
    Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 715–728, Laure Elens, Rachida Bouamar, Nauras Shuker, Dennis A. Hesselink, Teun van Gelder and Ron H. N. van Schaik

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12253

  2. You have free access to this content
    Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 364–372, Diego Alberto C. Cusinato, Riccardo Lacchini, Elen A. Romao, Miguel Moysés-Neto and Eduardo B. Coelho

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12345

  3. You have free access to this content
    Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation

    British Journal of Clinical Pharmacology

    Volume 80, Issue 4, October 2015, Pages: 630–641, Carlos Orlando Jacobo-Cabral, Pilar García-Roca, Elba Margarita Romero-Tejeda, Herlinda Reyes, Mara Medeiros, Gilberto Castañeda-Hernández and Iñaki F. Trocóniz

    Version of Record online : 22 JUN 2015, DOI: 10.1111/bcp.12649

  4. You have free access to this content
    Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 548–559, Hylke de Jonge, Thomas Vanhove, Henriëtte de Loor, Kristin Verbeke and Dirk R. J. Kuypers

    Version of Record online : 3 AUG 2015, DOI: 10.1111/bcp.12703

  5. You have free access to this content
    Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients

    British Journal of Clinical Pharmacology

    Volume 77, Issue 1, January 2014, Pages: 130–140, Mariam H. Abdel Jalil, Ahmed F. Hawwa, Patrick J. McKiernan, Michael D. Shields and James C. McElnay

    Version of Record online : 20 DEC 2013, DOI: 10.1111/bcp.12174

  6. You have free access to this content
    Renal drug metabolism in humans: the potential for drug–endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT)

    British Journal of Clinical Pharmacology

    Volume 76, Issue 4, October 2013, Pages: 587–602, Kathleen M. Knights, Andrew Rowland and John O. Miners

    Version of Record online : 24 SEP 2013, DOI: 10.1111/bcp.12086

  7. Measurement and Compartmental Modeling of the Effect of CYP3A5 Gene Variation on Systemic and Intrarenal Tacrolimus Disposition

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 6, December 2012, Pages: 737–745, S Zheng, Y Tasnif, M F Hebert, C L Davis, Y Shitara, J C Calamia, Y S Lin, D D Shen and K E Thummel

    Version of Record online : 17 OCT 2012, DOI: 10.1038/clpt.2012.175

  8. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

    Clinical Pharmacology & Therapeutics

    Volume 98, Issue 1, July 2015, Pages: 19–24, KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, D Wang, AA Vinks, Y He, JJ Swen, JS Leeder, RHN van Schaik, KE Thummel, TE Klein, KE Caudle and IAM MacPhee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/cpt.113

  9. In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 366–375, H de Jonge, H de Loor, K Verbeke, Y Vanrenterghem and D R Kuypers

    Version of Record online : 8 AUG 2012, DOI: 10.1038/clpt.2012.109

  10. Effect of Polymorphic CYP3A5 Genotype on the Single-Dose Simvastatin Pharmacokinetics in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 47, Issue 1, January 2007, Pages: 87–93, Dr Kyoung-Ah Kim, Dr Pil-Whan Park, Dr Ock-Je Lee, Dr Dong-Kyun Kang and Dr Ji-Young Park

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006295063

  11. You have full text access to this OnlineOpen article
    Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling

    British Journal of Clinical Pharmacology

    Volume 78, Issue 3, September 2014, Pages: 509–523, Elisabet Størset, Nick Holford, Stefanie Hennig, Troels K. Bergmann, Stein Bergan, Sara Bremer, Anders Åsberg, Karsten Midtvedt and Christine E. Staatz

    Version of Record online : 21 AUG 2014, DOI: 10.1111/bcp.12361

  12. Effect of CYP3A5 polymorphism on the pharmacokinetics of tacrolimus and acute rejection in renal transplant recipients: experience at a single centre

    International Journal of Clinical Practice

    Volume 69, Issue S183, May 2015, Pages: 16–22, Y. Cheng, H. Li, Y. Meng, H. Liu, L. Yang, T. Xu, J. Yu, N. Zhao and Y. Liu

    Version of Record online : 5 MAY 2015, DOI: 10.1111/ijcp.12662

  13. You have free access to this content
    Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients

    British Journal of Clinical Pharmacology

    Volume 77, Issue 6, June 2014, Pages: 1051–1063, Nastya Kassir, Line Labbé, Jean-Romain Delaloye, Mohamad-Samer Mouksassi, Anne-Laure Lapeyraque, Fernando Alvarez, Michel Lallier, Mona Beaunoyer, Yves Théorêt and Catherine Litalien

    Version of Record online : 22 MAY 2014, DOI: 10.1111/bcp.12276

  14. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 6, December 2009, Pages: 609–618, W Zhao, V Elie, G Roussey, K Brochard, P Niaudet, V Leroy, C Loirat, P Cochat, S Cloarec, J L André, F Garaix, A Bensman, M Fakhoury and E Jacqz-Aigrain

    Version of Record online : 28 OCT 2009, DOI: 10.1038/clpt.2009.210

  15. CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 527–538, Ranjana Mitra and Oscar B. Goodman Jr

    Version of Record online : 13 JAN 2015, DOI: 10.1002/pros.22940

  16. Reduced Methylprednisolone Clearance Causing Prolonged Pharmacodynamics in a Healthy Subject Was Not Associated With CYP3A5*3 Allele or a Change in Diet Composition

    The Journal of Clinical Pharmacology

    Volume 46, Issue 5, May 2006, Pages: 515–526, Dr Su-Jun Lee, Dr William J. Jusko, Ms Christine G. Salaita, Dr Karim A. Calis, Dr Michael W. Jann, Dr Vicky E. Spratlin, Dr Joyce A. Goldstein and Dr Yuen Yi Hon

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006287588

  17. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 2, April 2012, Pages: 295–306, D. Krishnakumar, Umamaheswaran Gurusamy, Kayathri Dhandapani, A. Surendiran, Ruchi Baghel, Ritushree Kukreti, Reneega Gangadhar, Ushakiran Prayaga, S. Manjunath and C. Adithan

    Version of Record online : 25 JAN 2011, DOI: 10.1111/j.1472-8206.2010.00917.x

  18. Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance

    British Journal of Clinical Pharmacology

    Volume 82, Issue 6, December 2016, Pages: 1539–1549, Thomas Vanhove, Hylke de Jonge, Henriëtte de Loor, Pieter Annaert, Ulf Diczfalusy and Dirk R. J. Kuypers

    Version of Record online : 20 SEP 2016, DOI: 10.1111/bcp.13083

  19. Effect of cytochrome P450 3A5*3 genotype on the stereoselective pharmacokinetics of amlodipine in healthy subjects

    Chirality

    Volume 21, Issue 5, May 2009, Pages: 485–491, Kyoung-Ah Kim, Pil-Whan Park and Ji-Young Park

    Version of Record online : 27 AUG 2008, DOI: 10.1002/chir.20588

  20. You have free access to this content
    Dosing equation for tacrolimus using genetic variants and clinical factors

    British Journal of Clinical Pharmacology

    Volume 72, Issue 6, December 2011, Pages: 948–957, Chaitali Passey, Angela K. Birnbaum, Richard C. Brundage, William S. Oetting, Ajay K. Israni and Pamala A. Jacobson

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1365-2125.2011.04039.x